Standard BioTools Cash on Hand 2012-2026 | LAB
Standard BioTools cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Standard BioTools Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $188 |
| 2024 | $293 |
| 2023 | $115 |
| 2022 | $166 |
| 2021 | $28 |
| 2020 | $69 |
| 2019 | $59 |
| 2018 | $95 |
| 2017 | $63 |
| 2016 | $59 |
| 2015 | $95 |
| 2014 | $115 |
| 2013 | $84 |
| 2012 | $80 |
| 2011 | $53 |
|
Standard BioTools Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $477 |
| 2026-03-31 | $455 |
| 2025-12-31 | $188 |
| 2025-09-30 | $195 |
| 2025-06-30 | $237 |
| 2025-03-31 | $258 |
| 2024-12-31 | $293 |
| 2024-09-30 | $366 |
| 2024-06-30 | $395 |
| 2024-03-31 | $462 |
| 2023-12-31 | $115 |
| 2023-09-30 | $129 |
| 2023-06-30 | $142 |
| 2023-03-31 | $155 |
| 2022-12-31 | $166 |
| 2022-09-30 | $185 |
| 2022-06-30 | $211 |
| 2022-03-31 | $30 |
| 2021-12-31 | $28 |
| 2021-09-30 | $29 |
| 2021-06-30 | $31 |
| 2021-03-31 | $50 |
| 2020-12-31 | $69 |
| 2020-09-30 | $72 |
| 2020-06-30 | $45 |
| 2020-03-31 | $48 |
| 2019-12-31 | $59 |
| 2019-09-30 | $63 |
| 2019-06-30 | $69 |
| 2019-03-31 | $75 |
| 2018-12-31 | $95 |
| 2018-09-30 | $36 |
| 2018-06-30 | $40 |
| 2018-03-31 | $47 |
| 2017-12-31 | $63 |
| 2017-09-30 | $62 |
| 2017-06-30 | $42 |
| 2017-03-31 | $50 |
| 2016-12-31 | $59 |
| 2016-09-30 | $71 |
| 2016-06-30 | $86 |
| 2016-03-31 | $95 |
| 2015-12-31 | $95 |
| 2015-09-30 | $97 |
| 2015-06-30 | $100 |
| 2015-03-31 | $116 |
| 2014-12-31 | $115 |
| 2014-09-30 | $95 |
| 2014-06-30 | $95 |
| 2014-03-31 | $143 |
| 2013-12-31 | $84 |
| 2013-09-30 | $64 |
| 2013-06-30 | $60 |
| 2013-03-31 | $80 |
| 2012-12-31 | $80 |
| 2012-09-30 | $86 |
| 2012-06-30 | $38 |
| 2012-03-31 | $39 |
| 2011-12-31 | $53 |
| 2011-09-30 | $59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.273B | $0.085B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |